TrialTrials2022

Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.

Graciela Cárdenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.